Morning versus evening dosing of desloratadine in seasonal allergic rhinitis: a randomized controlled study [ISRCTN23032971].
AUTOR(ES)
Haye, Rolf
FONTE
BioMed Central
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=549030Documentos Relacionados
- Enzyme potentiated desensitisation in treatment of seasonal allergic rhinitis: double blind randomised controlled study
- Treatment of seasonal allergic rhinitis: Useless versus helpful allergy therapy
- 24-hour efficacy of once-daily desloratadine therapy in patients with seasonal allergic rhinitis [ISRCTN32042139]
- Treatment of seasonal allergic rhinitis: Desensitisation for hay fever works
- Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials